Back to Journals » Patient Preference and Adherence » Volume 19
Colonoscopy Uptake in First-Degree Relatives of CRC Patients: Challenges and Intervention Strategies
Authors Liu W, Liu M, Li P, Hou Y, Zhao Q, Xing L, Wang Y, Fu C
Received 16 October 2024
Accepted for publication 12 March 2025
Published 29 March 2025 Volume 2025:19 Pages 855—868
DOI https://doi.org/10.2147/PPA.S501332
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Johnny Chen
Weihua Liu,1,* Mindi Liu,2,* Ping Li,3 YingHui Hou,1 Qing Zhao,1 Limei Xing,1 Ying Wang,4 Cong Fu5
1General Surgical Department, Affiliated Hospital of Hebei University, Baoding, People’s Republic of China; 2Wound Ostomy Clinic, Affiliated Hospital of Hebei University, Baoding, People’s Republic of China; 3Gastrointestinal Surgery Ward, Affiliated Hospital of Hebei University, Baoding, People’s Republic of China; 4Department of Integrated Traditional Chinese and Western Medicine, Affiliated Hospital of Hebei University, Baoding, People’s Republic of China; 5Department of Nursing, Affiliated Hospital of Hebei University, Baoding, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Cong Fu, Department of Nursing, Affiliated Hospital of Hebei University, No. 212 Yuhua East Road, Lianchi District, Baoding, Hebei, 071000, People’s Republic of China, Tel +86 0312-5981680, Email [email protected]
Objective: Colorectal cancer (CRC) screening is crucial for early detection and prevention. However, the willingness of first-degree relatives of CRC patients to undergo colonoscopy often remains low, impacting early diagnosis and treatment outcomes.
Methods: This article reviewed the relevant concepts, research status, evaluation methods, influencing factors and intervention measures of first-degree relatives of patients with colorectal cancer.
Results: Through the review, it is found that there is still a large gap in the research on the development of assessment tools and intervention programs. Existing intervention programs often fail to address the unique demographic, cognitive, psychological, family dynamic, and social barriers faced by this population. Future research should prioritize the development of specific assessment tools that can accurately measure the willingness of first-degree relatives to undergo colonoscopy, taking into account cultural nuances and contextual factors. By addressing psychological and social factors, researchers can develop more targeted and effective programs that enhance understanding and motivation for colonoscopy screening.
Conclusion: This study provides references for domestic research on the willingness of first-degree relatives for colonoscopy, provide new ideas for formulating intervention methods more suitable for first-degree relatives for colonoscopy, and promote their willingness to perform colonoscopy.
Keywords: colorectal cancer, first-degree relatives, enteroscopy, check intention
Introduction
In 2020, the number of new cases of colorectal cancer (CRC) in the world will be about 1.93 million, accounting for 10.0% of all new cancer cases, ranking third among all cancers. There were about 935,000 deaths, accounting for 9.4% of all cancer deaths, ranking second among all cancer deaths.1 In 2020, 555,000 new CRC cases were reported in China, accounting for 28.8% of the new CRC cases in the world, ranking second among all cancers in China. There were 286,000 CRC deaths, accounting for 30.6% of the global CRC deaths and ranking fifth among all cancer deaths in China.2 Colonoscopy is an important means to diagnose early colorectal cancer and precancerous lesions, and is recognized as the “gold standard” for diagnosis and treatment of intestinal lesions.3,4 First-degree relatives (FDRs) of CRC patients are at high risk for CRC development,5,6 including biological parents, children, and siblings of CRC patients. Results of a meta-analysis6 showed that the risk of first-degree relatives of colorectal cancer patients was 1.76 times that of the general population. Other studies7 show that the probability of developing the disease is also affected by the number of relatives with the disease. Current guidelines and studies4,5,8,9 strongly recommend colonoscopy screening of first-degree relatives (FDRs) of CRC patients starting at age 40 or 10 years younger than the earliest CRC diagnosis in the family. Research conducted in China primarily targets high-risk groups aged 50 to 75 years,10–14 with limited focus on studies specific to first-degree relatives. In China, insufficient public awareness of CRC and traditional cultural values that emphasize social dignity and discourage acknowledging physical discomfort have led to lower participation rates in screening programs. This psychological resistance is particularly pronounced for procedures such as colonoscopy, which require the exposure of private body areas. Family support plays a crucial role in the decision to undergo screening; however, poor communication within families can reduce screening willingness. Systemic barriers also exist, with high-quality medical resources concentrated in major cities, limiting access for residents in rural and remote areas. Economic burdens and complex health insurance reimbursement processes further hinder CRC screening efforts. Despite governmental and social organization initiatives, public understanding of CRC and its screenings requires further enhancement. Significant advancements have been made in colonoscopy technology and intervention measures in China. Innovations such as virtual colonoscopy and capsule endoscopy offer less invasive or more acceptable screening options, while artificial intelligence-assisted diagnostics enhance the speed and accuracy of image analysis. Intervention strategies include personalized health management plans tailored to individual risk profiles, multidisciplinary team collaborations for comprehensive services, psychological support to help patients overcome fear, and community education to increase public awareness and engagement in CRC prevention. These integrated measures aim to improve screening rates and the quality of care, ultimately enhancing overall prevention and control outcomes for CRC. This study summarized and summarized the concept, research status, assessment tools, influencing factors and intervention methods of colorectal cancer first-degree relatives’ willingness to perform colonoscopy, aiming to provide references for domestic research on the willingness of first-degree relatives to perform colonoscopy, and provide new ideas for formulating intervention methods more suitable for first-degree relatives’ willingness to perform colonoscopy.
Related Concepts
Colorectal Cancer
Colorectal cancer is a malignant neoplasm of the lower digestive tract originating from the mucosal epithelium of the colorectal lining. Its development typically progresses from adenoma (polyp) to carcinoma over a period of 10 to 15 years, providing ample opportunity for early detection and clinical intervention.15 In the early stages, colorectal cancer often presents without obvious symptoms. However, as the disease advances, particularly in later stages, symptoms such as hematochezia, melena, lower abdominal cramping, persistent constipation or diarrhea, decreased appetite, and unintended weight loss may emerge.16–18 Extensive research15,19 indicates that early screening for colorectal cancer in asymptomatic individuals, coupled with the detection of precancerous lesions and timely intervention, can interrupt the carcinogenic process, improve prognosis, reduce mortality, and enhance the quality of life for patients.
Colonoscopy
Colonoscopy is a frequently employed, direct, and effective method for detecting intestinal diseases and is regarded as the most accurate diagnostic tool for early colorectal cancer detection.3,20 Colonoscopy serves five primary functions in colorectal cancer screening: early detection of precancerous lesions, identification of asymptomatic adenomatous polyps (primary screening), follow-up on other screening abnormalities (diagnosis), removal of precancerous lesions (prevention), removal of early-stage cancer (treatment), and long-term surveillance of high-risk patients.9 The major advantage of colonoscopy lies in its ability to directly visualize the intestinal cavity, offering high accuracy and sensitivity in detecting early cancer and precancerous lesions, including advanced adenomas and intraepithelial neoplasia. A meta-analysis4 indicated that colonoscopy screening is associated with a 56% reduction in morbidity (RR=0.44, 95% CI: 0.22–0.88) and a 57% reduction in mortality (RR=0.43, 95% CI: 0.35–0.53) compared to no screening.
However, colonoscopy is an invasive procedure that can lead to complications such as perforation and bleeding.3 The preparation for colonoscopy often requires consuming large amounts of laxatives, which some individuals may find challenging, potentially leading to inadequate bowel preparation and affecting the examination’s efficacy.21 Additionally, the skill level of the endoscopist can influence the procedure’s outcome. These limitations contribute to reduced compliance with colonoscopy and reluctance among patients to undergo the procedure.
Wishes for Colonoscopy
The willingness of first-degree relatives of colorectal cancer patients to undergo colonoscopy is a behavior intention. Behavioral willingness refers to the subjective likelihood or inclination of an individual to engage in certain behaviors, and is closer to behaviors than factors such as beliefs, attitudes, and affection.22 And there is a high willingness to do these behaviors, and when this willingness is explained correctly, the behavior of doing cancer screening increases.23,24 The intention of first-degree relatives to undergo colonoscopy, that is, the behavioral intention of first-degree relatives to undergo colonoscopy, can predict the outcome of their actual behavior in undergoing colonoscopy.
Current Status of Colonoscopy Screening for First-Degree Relatives
Current Situation in Foreign Countries
At present, foreign scholars have conducted a number of studies on the status quo of colonoscopy screening of first-degree relatives of colorectal patients. A cross-sectional study conducted by Weigl et al25 in three German cities showed that 45.2%, 52.4% and 61.4% of first-degree relatives of colorectal cancer patients aged 40–44, 45–49 and 50–54 had received colonoscopy, respectively. Overall, there are about 54. 5% of first-degree relatives had undergone a colonoscopy, compared with 25.7% of those without a family history; A study in the United States26 showed that 74.7% of first-degree relatives with colorectal cancer had received colonoscopy in the past 10 years, and 56.6% of those with no family history had received colonoscopy. The colonoscopy screening rate of first-degree relatives of colorectal cancer patients in developed countries such as Europe and the United States is relatively high, and the screening rate is maintained at 45–75%.
Current Status of China
Domestic scholars have gradually paid attention to the status quo of colonoscopy screening of first-degree relatives of colorectal cancer patients. A study by Bai27 showed that the self-reported participation rate of first-degree relatives of colorectal cancer patients in colonoscopy screening was 15.6%; A study by Sun Yan28 showed that 22.4% of first-degree relatives with colorectal cancer had “colonoscopy in the past 5 years”; Du et al29 conducted a survey on 201 first-degree relatives of colorectal cancer patients, showing that only 18.9% of first-degree relatives had participated in colonoscopy. According to a study by the National Cancer Clinical Research Center of China,30 only 20.9% of first-degree relatives received colonoscopy. A qualitative study31 showed that even among first-degree relatives who were recommended for colonoscopy screening, their colonoscopy rate was only 25%. Wu’s32 study showed that 23% of first-degree relatives had received colonoscopy screening. The colonoscopy screening rate of first-degree relatives of colorectal cancer patients in China is low, and the screening rate is maintained at 15–25% (Table 1).
![]() |
Table 1 Current Status of Colonoscopy Screening for First-Degree Relatives |
A Study Tool on the Willingness of First-Degree Relatives of Colorectal Cancer Patients to Undergo Colonoscopy
Belief Tool for Colorectal Cancer Screening Based on HBM
Colorectal Cancer Cognition Scale (CRCPS)
CRCPS was developed by Green33 in 2004, and included 35 items in four dimensions: perceived susceptibility, perceived severity, perceived impairment and perceived benefit of colorectal cancer. Du et al29 translated it into Chinese after obtaining Green’s permission, and the Chinese-language scale was applicable to relatives of patients with colorectal cancer.7 items were deleted to form a Chinese-language cognitive scale of colorectal cancer consisting of 28 items in 4 dimensions, with Cronbach’s α coefficient >0.70 for each dimension. The Cronbach’s α coefficient of the total volume table is 0.74, indicating that the revised scale has good reliability and validity. Leung et al34 translated CRCPS from English into traditional Chinese. After exploratory factor analysis and confirmatory factor analysis, items related to perceived severity were classified into severe perceived fear and severe perceived life impact. The items related to perceptual disorders were divided into perceptual psychological disorders and perceptual knowledge disorders, and verified in the sample of community elderly people. The Cronbach’s α coefficients of the six subscales ranged from 0.74 to 0.88. An epidemiological study of the traditional Chinese version of CRCPS has been conducted in Hong Kong. Given that the tool was developed for CRC screening tests, some entries in the perception disorders dimension are not specific when applied to colonoscopy.
Revised Colorectal Cancer Perception Tool (RCRCPS)
RCRCPS is a combination of 35 items in the Colorectal Cancer Perception Scale (CRCPS)33 and 3 items in the Perceptual Disorders Questionnaire, which is used for colonoscopy, by Bai35 in 2020. There were 38 items in 4 dimensions, including susceptibility to CRC, perceived severity of CRC, perceived barriers to colonoscopy and perceived benefits of colonoscopy. Likert 5-level scores were used, ranging from “strongly disagree” to “strongly agree” with 1–5 points respectively. CRCPS scores ranged from 38 to 190 points. The higher the score, the higher the cognitive level. The Cronbach’s α coefficient was 0.74~0.87 in 197 immediate family members of Chinese patients with colorectal cancer, and the retest reliability was 0.53~0.84 within 4 weeks. The S-CVI ranges from 0.92, and the I-CVI ranges from 0.80 to 1.00. The 38-item simplified Chinese version of RCRCPS has good reliability and validity. It provides an effective tool for health care professionals to assess people at high risk of colorectal cancer, while also laying the foundation for the development of effective colorectal cancer screening interventions.
Colorectal Cancer Health Belief Model Scale (CCHBMS)
CCHBMS was adapted by Jacobs36 in 2002 based on the Champion Health Belief Model for Breast Cancer Patients (CHBMS)37 to assess the population’s health beliefs about colorectal cancer and its screening. There were 36 items in 6 dimensions, including perceived susceptibility to CRC, perceived severity of CRC, perceived barriers to CRC screening, perceived benefit of CRC screening, health motivation and self-efficacy of CRC screening. A Likert 5-level score ranging from “strongly disagree” to “strongly agree” was used to calculate the perceived barrier dimension score for colorectal cancer screening using a reverse scoring method. A higher score indicates a higher belief in appropriate health behaviors. The Cronbach’α coefficient of the colorectal cancer health Belief Scale ranged from 0.54 to 0.88, and the retest reliability ranged from 0.72 to 0.91. The Turkish version of CHBMS was compiled by Ozsoy et al38 in 2007 based on the Champion health belief model. There were 33 items in 5 dimensions, including perceived CRC susceptibility (6 items), perceived CRC severity (5 items), perceived CRC screening barriers (6 items), perceived CRC screening benefits (11 items), and health motivation (5 items). Cronbach’s coefficient of the five subscales ranged from 0.54 to 0.88. The retest reliability ranges from 0.72 to 0.91. The results show that the Turkish version of Champion Health Belief Pattern Scale has good reliability and validity, and can be used to measure colorectal cancer related beliefs. Wu et al39 introduced CCHBMS into China in 2020 and translated it into the Chinese version of the Colorectal Cancer Health Belief Scale. The Cronbach’s α coefficient of the total volume table was 0.881 and the Cronbach’s α coefficient of the 6 dimensions was 0.801~0.944 in 210 relatives of patients with colorectal cancer. The retest reliability is 0.848. S-CVI (0.98) and I-CVI (0.84~1.00) showed good reliability and validity, confirming that the six-factor structure is suitable for the Chinese cultural background, and can be used as an effective tool to evaluate the health belief level of high-risk groups of colorectal cancer in China. Although the scale is not as detailed as the Four-factor colorectal Cancer Screening Belief Scale in measuring the psychological structure of screening, it is widely used and has sufficient reliability.
Four-Factor Colorectal Cancer Screening Belief Scale (CRCSBS)
The four-factor Colorectal Cancer Screening Belief Scale (CRCSBS) was developed by Murphy40 in 2013 based on the relevant four-factor model,41 which is used to specifically measure people’s beliefs about CRC screening and is a tool to evaluate the psychosocial structure of CRC screening. The scale consisted of 33 items in 4 dimensions, including: perceived benefits of CRC screening (6 items), perceived barriers to CRC screening (11 items), self-efficacy (10 items), and optimism (6 items). A Likert 5-point scale was used, ranging from “strongly disagree” to “strongly agree”, with an overall scale score between 33 and 165. The higher the score, the more positive the belief in screening. The Cronbach’α coefficient of each dimension was 0.822–0.964, LiuYang42 equivalent to introducing CRCSBS into China in 2022 and translating it into the Chinese version of the Four-factor Screening Belief Scale for colorectal cancer. In 425 colorectal cancer patients and their relatives, the McDonald’s omega of the whole scale is 0.939, the McDonald’s omega of four dimensions is 0.774 to 0.948, the retest reliability of the scale is 0.719, and the retest reliability coefficient of each dimension is 0.664 to 0.768. The broken half reliability is 0.646. The Chinese version of the four-factor colorectal cancer screening Belief Scale has good reliability and validity. The translation and validation of psychosocial assessment tools for colorectal cancer screening across languages, cultures and countries will contribute to further international research cooperation, provide a prerequisite for healthcare professionals to improve the population’s belief in colorectal cancer screening, and have important significance in promoting screening behavior and preventing the occurrence of colorectal cancer.
Adapted Health Literacy Management Scale HeLMS (Health Literacy Management Scale)
The adapted version of HeLMS was translated and revised by Sun Haolin43 in 2012 using the HeLMS scale prepared by Jordan et al44 of the University of Melbourne, Australia, to assess the health literacy level of the study subjects. The scale consists of 4 dimensions and 24 items, including the ability to obtain health information (10 items), the ability to communicate and interact (8 items), the willingness to improve health (4 items), and the willingness to provide economic support (2 items). The Cronbach’α coefficient of the total volume table was 0.894, and the retest reliability was 0.683, both of which were greater than 0.60, indicating that the scale had good reliability and validity. The adapted version of HeLMS was evaluated for reliability and validity by Peng Hui et al.45 The Cronbach’α coefficient of the scale was 0.961, and the Cronbach’α coefficient of each dimension was 0.834~0.929. At the same time, the correlation coefficient between the score of the four dimensions and the total score of the scale is 0.517–0.916, which has good validity and reliability in the positive population of colorectal cancer. Muzaibel Muhetal46 applied it to the study on the impact of health literacy on colonoscopy compliance of colorectal cancer positive primary screening population, and the results showed that community residents’ HeLMS communication and interaction ability and willingness to improve health were influencing factors for colonoscopy compliance of colorectal cancer positive primary screening population.
Intention Questionnaire for Colorectal Cancer Screening Based on Protective Motivation Theory
The intention questionnaire for colorectal cancer screening based on the theory of protective motivation was developed by Wei Wenshuang et al47 in 2021 through literature review, expert consultation and pre-investigation. To evaluate colorectal cancer screening intention and behavior of urban residents. The questionnaire consisted of 6 dimensions and 16 items, including risk perception (2 items), severity perception (2 items), fear perception (2 items), response efficacy (3 items), response cost (3 items), and self-efficacy (4 items). The cumulative variance contribution rate of the extracted common factors was 67.657%, the Cronbach’s α coefficient of the total questionnaire was 0.763, and the Cronbach’s α coefficient of each dimension was 0.584 ~ 0.771. The correlation coefficient between items in the six dimensions ranged from 0.089 to 0.534, and the correlation coefficient between each dimension and the total questionnaire ranged from 0.165 to 0.586. The results show that the questionnaire has good reliability and validity, which can help clinical nurses to understand the barriers of colorectal cancer screening in Chinese urban residents, and provide scientific guidance for nursing staff to carry out health education and other activities to encourage screening (Table 2).
![]() |
Table 2 Research Tool for Colonoscopy in First-Degree Relatives of Colorectal Cancer Patients |
Factors Influencing the Willingness of First-Degree Relatives to Undergo Colonoscopy in Patients With Colorectal Cancer
Personal Factors
Demographic Factors
The willingness of first-degree relatives of colorectal cancer patients to undergo colonoscopy was correlated with age, sex, education, marital status, working status, residence and medical insurance. ① Age. A study by Du et al29 showed that the colonoscopy compliance of first-degree relatives of colorectal cancer patients aged 35–54 years (16%) was higher than that of first-degree relatives over 54 years (3%). A study by Weigl et al25 showed that the proportion of first-degree relatives receiving colonoscopy was negatively correlated with the age of diagnosis of the affected relatives. The younger the age of diagnosis of colorectal cancer patients, the higher the proportion of their first-degree relatives receiving colonoscopy; the higher the age of diagnosis of colorectal cancer patients, the lower the risk of colorectal cancer their first-degree relatives thought. Sun Yan’s28 study showed that first-degree relatives older than 50 years had a serious lack of awareness of their own risk of colorectal cancer and colonoscopy screening. ② Gender. The results of a study in the United States26 showed that among first-degree relatives of colorectal cancer patients, women were more likely to adhere to colonoscopy than men, which is consistent with Wu’s48 study, possibly because women are more concerned about their health than men; Another study by Wu32 showed that men were more willing to accept colonoscopy than women, possibly because women were more likely to have fear and embarrassment about colonoscopy. ③ Education level: The higher the education level, the higher the willingness of first-degree relatives of colorectal cancer patients to undergo colonoscopy;29,32 According to the study of Sun Yan et al,28 the higher the education level of first-degree relatives, the higher their cognition level of colonoscopy. ④ Marital status. Married first-degree relatives’ intention to undergo colonoscopy was higher than unmarried and divorced ones.29,32 ⑤ Working status. A study by Du et al29 showed that first-degree relatives of colorectal cancer patients with stable jobs had a higher willingness to undergo colonoscopy. ⑥ Residence. First-degree relatives of colorectal cancer patients living in urban areas are more willing to undergo colonoscopy than those in rural areas,29,32 and their awareness level of colonoscopy is also higher than that in rural areas.28 ⑦ Medical insurance. A study by Shapiro et al49 found that only 44% of uninsured people aged 50–64 received a colonoscopy, compared to 57% of those with insurance; The willingness of first-degree relatives with medical insurance to undergo colonoscopy was significantly higher than that of those without medical insurance.32
Individual Cognitive Factors
The cognitive level of first-degree relatives of colorectal cancer patients is positively correlated with screening intention.32,48 A study by Bai27 showed that 31.4% of first-degree relatives did not understand the process of colonoscopy, and a qualitative study by Zhang31 showed that for first-degree relatives of colorectal cancer, cancer is equivalent to terminal illness and death, and people usually avoid discussing cancer-related topics. Influenced by cancer fatalism, some first-degree relatives believe that their risk of cancer is not affected by their own behavior, that everything is predestined and cannot be escaped or changed, and that screening is meaningless if they are destined to get cancer. There are also people who believe that the disease is related to heredity and there is no way to change it, even if it is checked. Still others believe that the absence of symptoms is healthy,28,50–52 and that normal annual physical examination results mean good health,28 which takes them away from the perception of disease and makes them feel that deliberate colonoscopy screening is not necessary. A study by Sun Yan28 showed that 73.5% of first-degree relatives did not consider themselves to be a high-risk group for colorectal cancer. This is consistent with the findings of McGarragle et al53 that first-degree relatives consider their risk of CRC to be low or negligible.
Personal Psychological Factors
First-degree relatives of colorectal cancer patients think that colonoscopy will be very painful and fear that they will detect colorectal cancer;27,28,51 A study in Saudi Arabia54 showed that fear was a common barrier to colonoscopy. The possible adverse consequences of screening will directly break the current “healthy” state, or even the balance of a good life, and let them fall into fear and worry;31 81.6% of first-degree relatives were afraid of the colonoscopy process,28 such as the preparation of colon cleansing before the examination, embarrassment during the examination, pain and adverse reactions to anesthesia. Some immediate family members53,55 indicated that they preferred to be kept in the dark about CRC and feared the bad news that colonoscopy could bring.
Family Factors
The willingness of first-degree relatives of colorectal cancer patients to undergo colonoscopy is also affected by family factors. A qualitative study31 showed that although some immediate family members understood the importance of colonoscopy screening, their daily lives were consumed by complex work, parental care, parenting, and other events, often leaving them with a sense of powerlessness. As a result, screening is not a priority in their lives and is often delayed when work - or family-related issues arise at the same time; The suggestion of siblings (encouragement and persuasion) is a motivating factor for their first-degree relatives to undergo colonoscopy.50 According to the study of McGarragle et al,53 25% of colorectal cancer patients did not mention any information about colorectal cancer and colonoscopy to their first-degree relatives. The first reason is that colorectal cancer patients lack relevant information about colorectal cancer and guidelines for colonoscopy screening. The second is the negative expectation of family reaction; The third is that the first degree relatives know the information about colorectal cancer or have undergone colonoscopy; Fourth, they are estranged from first-degree relatives for a long time, do not want to talk about health problems, and do not want first-degree relatives to think that trying to contact them is to gain sympathy; Cultural barriers and strong stigma prevent them from disclosing the increased risk of CRC and the necessity of colonoscopy to their first-degree relatives, which are also important factors influencing their first-degree relatives to undergo colonoscopy.
Social Factors
The willingness of first-degree relatives of colorectal cancer patients to undergo colonoscopy is also affected by social factors. (1) Doctor’s advice. A study by Fiala26 showed that: the proportion of first-degree relatives who did not accept the doctor’s recommendation to undergo colonoscopy was 74.7%, and 94% of first-degree relatives of patients with colorectal cancer who followed the doctor’s screening recommendation received colonoscopy; A domestic study28 showed that 75.5% of FDRs did not get enough information about CRC screening from doctors. According to SalimzadehH,51 46.2% of first-degree relatives never received a doctor’s recommendation for CRC screening; The physician’s recommendation is a motivating factor for first-degree relatives to undergo colonoscopy.32,53 However, Ingrand et al’s56 study showed that physicians’ lack of understanding of screening guidelines for colorectal cancer, lack of time, and not thinking of themselves as participants in the information flow about family risk prevented first-degree relatives from undergoing colonoscopy. (2) Inconvenient transportation. A qualitative study31 showed that “distance from the hospital and need to be picked up by children” were important factors for their reluctance to undergo colonoscopy. 26.3% of FDRs believe that there is no convenient and trusted medical institution near their place of residence for examination.28(3) Government subsidies: Tan et al50 showed that medical subsidies could promote first-degree relatives to undergo colonoscopy, and they agreed to free colonoscopy. The study of Wu et al32 shows that free medical treatment is a promoting factor for first-degree relatives to perform colonoscopy screening. (4) Social propaganda. Government propaganda through TV and other media and community encouragement are conducive to first-degree relatives to undergo colonoscopy, while the lack of posters in hospitals hinders their awareness of screening.50
Screening Technical Factors
Screening technical factors also affect the willingness of first-degree relatives of colorectal cancer patients to undergo colonoscopy. A qualitative study31 showed that the complicated and time-consuming process of colonoscopy was an important factor affecting the colonoscopy. A domestic study28 shows that 76.3% of first-degree relatives are busy with daily work, think colonoscopy is cumbersome and have no time to make appointment arrangements, and 60.5% FDRs worry that colonoscopy will cause harm to the body. According to the study of McGarragle et al,53 intestinal preparation before examination, embarrassment of examination site, and sedation during examination are the hindrance factors affecting colonoscopy.
Other Factors
In addition to demographic factors, personal factors, social factors and screening technology factors, there are other factors that affect the willingness of colorectal cancer patients to undergo colonoscopy. (1) Causes of other diseases. A study by PaskettED et al52 showed that 33.3% of first-degree relatives did not have a colonoscopy given other priorities or health concerns. (2) Time. A qualitative study53 showed that because of the tight schedule, they were embarrassed to ask for leave and gave up the colonoscopy; 32.4% of first-degree relatives did not undergo colonoscopy because of insufficient time.52 (3) Screening costs. It is believed that the high cost of screening and the financial burden are the hindering factors affecting their first-degree relatives to undergo colonoscopy28,50 (Table 3).
![]() |
Table 3 Factors Influencing the Willingness of First-Degree Relatives to Undergo Colonoscopy in Patients With Colorectal Cancer |
Interventions
Empirical and theory-oriented individualized communication models: Bai et al57 divided first-degree relatives of patients with colorectal cancer into control group and experimental group. Both groups received electronic pamphlets about colorectal cancer screening (risk factors for colorectal cancer, screening recommendations and free CRC screening programs in community Settings). The experimental group then received three carefully designed sessions of tailored communication (tailored based on a health belief model and consisting of two written messages and an oral consultation). Results58 showed that at 1 and 3 months after intervention, CRC susceptibility perception, CRC severity perception, colonoscopy benefit perception, colonoscopy self-efficacy perception and colonoscopy action cues were significantly improved. Colonoscopy barriers were significantly reduced. This evidence - and theory-driven, tailored communication approach significantly improves colonoscopy screening rates for first-degree relatives of patients with colorectal cancer.
Motivational interviewing: Motivational interviewing is a patient-centered and motivational method of counseling in which the counselor helps change the patient’s behavior by exploring and eliminating ambivalence. Salimzadeh et al51 randomly divided the first-degree relatives of patients with colorectal cancer into the experimental group and the control group. The first-degree relatives of the control group received information on colorectal cancer screening standards and routine care, while the first-degree relatives of the experimental group received phone-based motivational interview counseling with the participation of trained nurses or medical staff. Comparing the colonoscopy rates of the two groups after 6 months, the results showed that the proportion of colonoscopy screening was 83.5% in the intervention group and 48.2% in the control group. Demonstrated the effectiveness of phone-based motivational interview counseling in increasing colonoscopy for family members of colon cancer patients. Bauer et al59 used a computer system to randomly split 261 eligible first-degree relatives into an experimental group and a control group, both of whom were delivered study documents and information leaflets containing information on familial risk and CRC screening by their relatives with colorectal cancer in person or by mail. FDRS in the treatment group underwent telephone consultations with specially trained caregivers at the study Coordination Center (an average duration of 26.6 minutes), and the purpose of these conversations was to identify barriers to colonoscopy screening and then overcome them through consultations. In addition, information is provided on the sensitivity, specificity, and complications of colonoscopy and other screening methods. First-degree relatives in the control group received only the study document and an information leaflet. Written questionnaires were sent to both groups at 3 and 6 months after the start of the study. The results showed that 99 (79%) of 125 people in the experimental group and 97 (71%) of 136 people in the control group underwent colonoscopy, with no statistically significant difference between the two groups. The possible reason is that there is sample selection bias in contacting first-degree relatives of colorectal cancer patients, which can be further verified by increasing sample size and narrowing selection bias in future studies.
Based on the facilitator intervention, Paskett et al52 randomly divided first-degree relatives into an experimental group and a control group, which received only a site-based intervention (complete a survey of demographic characteristics and health-related characteristics via the web, and generate an individual colorectal cancer screening recommendation document based on NCCN guidelines, indicating when colonoscopies are needed and recommendations for individual health behaviors), the study group added facilitators (facilitators provide telephone follow-up based on each participant’s barriers and needs, and facilitators call participants 1 month after receiving the website recommendations to assess screening barriers and provide counseling for eliminating these barriers. And assisted participants in scheduling colonoscopies). The intervention of. Both groups received a call from the study staff to give their consent and complete the baseline survey. The findings showed that among first-degree relatives who needed immediate colonoscopy, adding a telephone referral to the website was more effective than colonoscopy compliance among participants who had the website intervention alone. May reduce the future incidence of CRC in first-degree relatives.
For tailored face-to-face or telephone interventions, Esplen et al60 randomly divided first-degree relatives who completed baseline assessment into three groups: a control group and two experimental groups. The control group received written information on CRC risk and screening recommendations; Treatment group 1 received advice on CRC risk and screening based on face-to-face counseling; Treatment Group 2 received advice on CRC risk and screening based on a telephone consultation format. The results showed that both telephone and face-to-face interventions improved first-degree relatives’ knowledge of CRC, risk perception, and willingness to screen compared with conventional treatment. Face-to-face intervention increased the satisfaction of first-degree relatives with CRC screening. A Mate analysis by Bai61 showed that a pooled analysis of four included studies showed that tailored communication had a beneficial effect on improving colonoscopy screening rates (OR: 2.21, 95% CI: 1.71–2.85, p<0.01). Telephone plus Print: A pooled analysis of three studies of repeated application of customized interventions through printed materials and telephone consultations showed a benefit in improving colonoscopy participation (OR: 2.39, 95% CI: 1.78–3.21, p<0.01).
Enlightenment
Attention Should Be Paid to the Study on the Willingness of First-Degree Relatives of Patients with Colorectal Cancer to Undergo Colonoscopy
In China, the willingness of first-degree relatives of patients with colorectal cancer is generally low, which seriously affects the compliance rate of colonoscopy screening, thereby increasing the diagnosis rate of advanced colorectal cancer, and seriously affecting the recovery and quality of life of first-degree relatives. One of the important factors affecting the willingness of first-degree relatives to colonoscopy is psychological factors. Future studies should focus on studying the factors affecting the willingness of first-degree relatives to colonoscopy from the perspective of social psychology, so as to open up a new path for psychological nursing of first-degree relatives and provide new ideas for nursing staff to formulate corresponding psychological nursing measures. Most studies on first-degree relatives of patients with colorectal cancer are small samples, and there is a lack of studies on large samples. Future studies should focus on increasing the sample size of first-degree relatives, reducing bias and improving the credibility of the study.
To Develop a Specific Assessment Tool for the Willingness of First-Degree Relatives of Colorectal Cancer Patients to Undergo Colonoscopy
At present, the assessment tools for studying the willingness of first-degree relatives of patients with colorectal cancer are mostly universal or adapted tools, while there are few specific scales for studying the willingness of first-degree relatives to undergo colonoscopy. Bai et al applied the revised Colorectal Cancer Perception Tool (RCRCPS) to first-degree relatives, and found through comparison with domestic and foreign descriptive studies, There are limitations in the dimensions contained in the scale, such as the lack of assessment of fatalism and other dimensions. Future research suggestions should integrate existing domestic and foreign high-quality assessment tools or develop new specific assessment tools on the basis of learning from domestic and foreign assessment tools, fully combining China’s cultural background and medical environment, and according to the characteristics of colonoscopy and the psychological characteristics of first-degree relatives. By increasing the sample size, we can improve the validation of the reliability and validity of the evaluation tool.
Explore More Interventions That Can Promote the Willingness of First-Degree Relatives of Patients With Colorectal Cancer to Undergo Colonoscopy
At present, there are few intervention measures for high-risk groups of colorectal cancer in China, and almost zero intervention measures for first-degree relatives of patients with colorectal cancer. Future studies suggest combining factors affecting the willingness of first-degree relatives for colonoscopy, searching for intervention breakthroughs, implementing precise interventions, and focusing on exploring intervention measures that are conducive to improving the screening rate of first-degree relatives for colonoscopy.
Conclusion
Improving the willingness of first-degree relatives to undergo colonoscopy is essential for enhancing colorectal cancer screening rates. Key factors influencing willingness include demographics, cognitive and psychological barriers, family dynamics, and social and technical aspects of screening. Effective interventions, such as tailored communication and motivational interviewing, address these barriers by increasing understanding and motivation. Psychological factors like fear and fatalism, along with insufficient support from healthcare providers, hinder screening. The intervention measures proposed in this study, such as personalized communication and motivational interviewing, hold significant practical implications. These interventions address specific concerns and misconceptions, thereby reducing psychological barriers and enhancing the autonomous decision-making ability of first-degree relatives, which in turn improves screening compliance and outcomes for early detection and treatment. In future research, investigators can introduce innovative intervention methods to enhance the willingness of FDRs to undergo colonoscopy, including personalized health education programs tailored to individual risk factors and psychological states, community support networks utilizing peer education and support groups to bolster confidence and adherence, and digital tools such as mobile applications or online platforms for appointment reminders, health consultations, and follow-up services. Future research should expand sample sizes to validate the effectiveness of these interventions, develop innovative strategies to further increase screening rates, and ultimately improve early detection of colorectal cancer among first-degree relatives.
Data Sharing Statement
All data generated or analysed during this study are included in this article. Further enquiries can be directed to the corresponding author.
Ethics Approval and Consent to Participate
An ethics statement is not applicable because this study is based exclusively on published literature.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
2. Zhou X, Hu M, Li ZS, et al. Prevalence of colorectal cancer in China and the world in 2020. J Naval Med Univ. 2022;43(12):1356–1364.
3. Lin JS, Perdue LA, Henrikson NB, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force. JAMA. 2021;325(19):1978–1998. doi:10.1001/jama.2021.4417
4. Chen W, Li N, Lan P, et al. Chinese guidelines for colorectal cancer screening and early diagnosis and treatment (2020, Beijing). China Oncology. 2019;30(01):1–28.
5. Kolb JM, Molmenti CL, Patel SG, et al. Increased risk of colorectal cancer tied to advanced colorectal polyps: an untapped opportunity to screen first-degree relatives and decrease cancer burden. Am J Gastroenterol. 2020;115(7):980–988. doi:10.14309/ajg.0000000000000639
6. Wong MCS, Chan CH, Lin J, et al. Lower relative contribution of positive family history to colorectal cancer risk with increasing age: a systematic review and meta-analysis of 9.28 million individuals. Am J Gastroenterol. 2018;113(12):1819–1827. doi:10.1038/s41395-018-0075-y
7. Roos VH, Mangas-Sanjuan C, Rodriguez-Girondo M, et al. Effects of family history on relative and absolute risks for colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(13):2657–2667. doi:10.1016/j.cgh.2019.09.007
8. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Gastroenterology. 2017;153(1):307–323. doi:10.1053/j.gastro.2017.05.013
9. Li N, Lu B, Luo C, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and Northern America. Cancer Lett. 2021;522:255–268. doi:10.1016/j.canlet.2021.09.034
10. Shi MM, Liang D, Shi J, et al. Screening and follow-up results of colorectal cancer in urban areas of Hebei Province from 2016 to 2022. China Oncology. 2023;32(6):423–430.
11. Li K, Liang YR, Qin PZ, et al. Analysis of pilot colorectal cancer screening results in 40 ~ 74 years old community population in Guangzhou from 2015 to 2018. China Oncology. 2019;32(01):39–45.
12. Fan XK, Ding H, Lu SB, et al. Analysis of colonoscopy compliance and its influencing factors in high risk population of colorectal cancer in Jiangsu Province. China Oncology. 2019;32(03):202–208.
13. Du J, Zhang Y, Liu X, et al. Analysis of colorectal cancer screening results of urban residents in Chongqing City from 2012 to 2019. China Oncology. 2019;31(05):355–360.
14. Li N, Xiao HB, Yan SP, et al. Participation rate, lesion detection rate and influencing factors of colorectal cancer screening in urban residents of Hunan Province from 2019 to 2020. China Oncology. 2021;30(08):600–607.
15. Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0
16. Skalitzky MK, Zhou PP, Goffredo P, et al. Characteristics and symptomatology of colorectal cancer in the young. Surgery. 2023;173(5):1137–1143. doi:10.1016/j.surg.2023.01.018
17. Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.21601
18. Mozafar Saadati H, Khodamoradi F, Salehiniya H. Associated factors of survival rate and screening for colorectal cancer in Iran: a systematic review. J Gastrointest Cancer. 2020;51(2):401–411. doi:10.1007/s12029-019-00275-0
19. Sharma T. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults. Public Health. 2020;182:70–76. doi:10.1016/j.puhe.2020.01.021
20. Gao Y, Gong Y, Du X, et al. Progress of early screening for colorectal cancer. Mod Preventive Med. 2019;47(16):3039–3042. (in Chinese).
21. Davidson KW, Barry MJ, Mangione CM, et al.; US Preventive Services Task Force. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2021;325(19):1965–1977. doi:10.1001/jama.2021.6238
22. Fishbein M, Ajzen I. Belief, attitude, intention, and behavior: an introduction to theory and research. Contemp Sociol. 1977;6:244. doi:10.2307/2065853
23. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179–211.
24. Khani Jeihooni A, Darvishi N, Harsini PA. The effect of educational intervention based on the theory of planned behavior on mammography screening in Iranian women. J Cancer Educ. 2020;35(2):264–273. doi:10.1007/s13187-018-1460-3
25. Weigl K, Tikk K, Hoffmeister M, et al. Prevalence of a First-degree relative with colorectal cancer and uptake of screening among persons 40 to 54 years old. Clin Gastroenterol Hepatol. 2020;18(11):2535–2543. doi:10.1016/j.cgh.2019.11.044
26. Fiala MA. Screening recommendation adherence among first-degree relatives of individuals with colorectal cancer. Transl Behav Med. 2022;12(8):853–859. doi:10.1093/tbm/ibac048
27. Bai Y, Wong CL, Peng X, et al. Colonoscopy screening behaviour and associated factors amongst first-degree relatives of people with colorectal cancer in China: testing the health belief model using a cross-sectional design. Int J Environ Res Public Health. 2020;17(14):4927. doi:10.3390/ijerph17144927
28. Sun Y, Dong X, Li D, et al. Investigation and analysis of first-degree relatives’ cognition status of colorectal cancer screening in patients with colorectal cancer. J Jilin Univ. 2022;48(4):1065–1070.
29. Du Q, Chen J, Meng Y, et al. Factors associated with colorectal cancer screening among first-degree relatives of patients with colorectal cancer in China. Cancer Nurs. 2022;45(2):E447–E453. doi:10.1097/NCC.0000000000000985
30. Chen H, Li N, Ren J, et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut. 2019;68(8):1450–1457. doi:10.1136/gutjnl-2018-317124
31. Zhang X, Zhang Y, Chen J, et al. Psychological distance: a qualitative study of screening barriers among first-degree relatives of colorectal cancer patients. BMC Public Health. 2021;21(1):716. doi:10.1186/s12889-021-10786-w
32. Wu X, Guo Z, Qiu X, et al. Study on colorectal cancer cognition, attitude and screening behavior of first-degree relatives of patients with inherited colorectal cancer. Chin J Nurs Manag. 2020;20(11):1627–1632.
33. Green PM, Kelly BA. Colorectal cancer knowledge, perceptions, and behaviors in African Americans. Cancer Nurs. 2004;27(3):
34. Leung DY, Wong EM, Chan CW. Psychometric properties of a Chinese version of the colorectal cancer perceptions scale in a sample of older Chinese people. Cancer Nurs. 2014;37(5):E53–60. doi:10.1097/NCC.0000000000000107
35. Bai Y, So WK, Wong CL. Translation, adaptation, and validation of revised colorectal cancer perception and screening instrument among first-degree relatives of people with colorectal cancer in China. Asia Pac J Oncol Nurs. 2020;7(2):180–189. doi:10.4103/apjon.apjon_6_20
36. Jacobs LA. Health beliefs of first-degree relatives of individuals with colorectal cancer and participation in health maintenance visits: a population-based survey. Cancer Nurs. 2002;25(4):251–265. doi:10.1097/00002820-200208000-00001
37. Champion VL. Instrument development for health belief model constructs. ANS Adv Nurs Sci. 1984;6(3):73–85. doi:10.1097/00012272-198404000-00011
38. Ozsoy SA, Ardahan M, Ozmen D. Reliability and validity of the colorectal cancer screening belief scale in Turkey. Cancer Nurs. 2007;30(2):139–145. doi:10.1097/01.NCC.0000265012.25430.30
39. Wu X, Zhang M, Zheng M, et al. Sinicization and validity of health belief scale for colorectal cancer. Chin J Gen Med. 2019;23(2):155–160. (in Chinese).
40. Murphy CC, McQueen A, Bartholomew LK, et al. Factorial validity and invariance of four psychosocial constructs of colorectal cancer screening: does screening experience matter? Cancer Epidemiol Biomarkers Prev. 2013;22(12):2295–2302. doi:10.1158/1055-9965.EPI-13-0565
41. McQueen A, Tiro JA, Vernon SW. Construct validity and invariance of four factors associated with colorectal cancer screening across gender, race, and prior screening. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2231–2237. doi:10.1158/1055-9965.EPI-08-0176
42. Yang L, Zhao R, Li S, et al. Psychometric properties of a Chinese version of four-factor colorectal cancer screening belief scale. Asia Pac J Oncol Nurs. 2022;9(9):100081. doi:10.1016/j.apjon.2022.100081
43. Sun H, Peng H, Fu H. Reliability and validity of health literacy scale for chronic disease patients. Fudan J. 2012;39(3):268–272. (in Chinese).
44. Jordan JE, Buchbinder R, Osborne RH. Conceptualising health literacy from the patient perspective. Patient Educ Couns. 2010;79(1):36–42. doi:10.1016/j.pec.2009.10.001
45. Peng H, Huang F, Wang Q, et al. Evaluation of the applicability of Health Literacy Management Scale (HeLMS) in primary screening positive residents of colorectal cancer. J Fudan Univ. 2019;46(03):338–343. (in Chinese).
46. Muhe TR, Jin H, Yu D. Effect of health literacy on colonoscopy compliance in patients with colorectal cancer with positive primary screening. Chin Gen Med. 2022;25(31):3944–3948.
47. Wei WS, Li QM, Zhang M, et al. Preparation and reliability test of colorectal cancer screening questionnaire based on protective motivation theory. Chin J Nurs. 2021;38(05):29–32.
48. Wu X, Gu J, Wang L, et al. Analysis of colorectal cancer cognition level and related factors in first-degree relatives of patients with inherited colorectal cancer. Chin J Pract Nurs. 2019;36(2):81–87.
49. Shapiro JA, Soman AV, Berkowitz Z, et al. Screening for colorectal cancer in the United States: correlates and time trends by type of test. Cancer Epidemiol Biomarkers Prev. 2021;30(8):1554–1565. doi:10.1158/1055-9965.EPI-20-1809
50. Tan KK, Lim TZ, Chew E, et al. Colorectal cancer patients can be advocates for colorectal cancer screening for their siblings: a study on siblings’ perspectives. Psychooncology. 2020;29(12):2028–2032. doi:10.1002/pon.5496
51. Salimzadeh H, Khabiri R, Khazaee-Pool M, et al. Motivational interviewing and screening colonoscopy in high-risk individuals. A randomized controlled trial. Patient Educ Couns. 2018;101(6):1082–1087. doi:10.1016/j.pec.2018.01.015
52. Paskett ED, Bernardo BM, Young GS, et al. Comparative effectiveness of two interventions to increase colorectal cancer screening for those at increased risk based on family history: results of a randomized trial. Cancer Epidemiol Biomarkers Prev. 2020;29(1):3–9. doi:10.1158/1055-9965.EPI-19-0797
53. McGarragle KM, Hare C, Holter S, et al. Examining intrafamilial communication of colorectal cancer risk status to family members and kin responses to colonoscopy: a qualitative study. Hered Cancer Clin Pract. 2019;17:16. doi:10.1186/s13053-019-0114-8
54. Abuadas FH, Alsharari AF, Abuadas MH. Predictors of colorectal cancer screening among average and high-risk Saudis population. J Pers Med. 2022;12(5):662. doi:10.3390/jpm12050662
55. Tan KK, Lopez V, Wong ML, et al. Uncovering the barriers to undergoing screening among first degree relatives of colorectal cancer patients: a review of qualitative literature. J Gastrointest Oncol. 2018;9(3):579–588. doi:10.21037/jgo.2018.03.02
56. Ingrand I, Palierne N, Sarrazin P, et al. Familial colonoscopic screening: how do French general practitioners deal with patients and their high-risk relatives. A qualitative study. Eur J Gen Pract. 2022;28(1):182–190. doi:10.1080/13814788.2022.2089353
57. Bai Y, Cho Lee W, Li G, et al. Development and feasibility of an evidence-based and theory-driven tailored mHealth communication intervention to increase colonoscopy screening rate in first-degree relatives of people with colorectal cancer. Eur J Oncol Nurs. 2022;56:102063. doi:10.1016/j.ejon.2021.102063
58. Bai Y, Wong CL, Peng X, et al. Effectiveness of a tailored communication intervention on colonoscopy uptake for first degree relatives of colorectal cancer patients: a randomized controlled trial. Asia Pac J Oncol Nurs. 2022;9(9):100068. doi:10.1016/j.apjon.2022.04.007
59. Bauer A, Riemann JF, Seufferlein T, et al. Invitation to Screening Colonoscopy in the Population at Familial Risk for Colorectal Cancer. Dtsch Arztebl Int. 2018;115(43):715–722. doi:10.3238/arztebl.2018.0715
60. Esplen MJ, Harrington S, Leung YW, et al. Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: a randomized controlled trial. Cancer. 2019;125(13):2272–2282. doi:10.1002/cncr.32032
61. Bai Y, Wong CL, He X, et al. Effectiveness of tailored communication intervention in increasing colonoscopy screening rates amongst first-degree relatives of individuals with colorectal cancer: a systematic review and meta-analysis. Int J Nurs Stud. 2020;101:103397. doi:10.1016/j.ijnurstu.2019.103397
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.